Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine mouthwash versus distilled water oral care in critically ill children
PACTR202601665742072Completed
- Sponsor
- Dr. Ahmed Ahmed Sayed Elnawawy
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chlorhexidine in ventilator-associated pneumonia (VAP), ventilator-associated condition (VAC), Maxillofacial Disorders and 2 more (2 arms), sponsored by Dr. Ahmed Ahmed Sayed Elnawawy. Primary endpoints: PICU mortality, Incidence of ventilator-associated condition and 3 more. Started Dec 2023; status: completed.
02
Drugs
chlorhexidine
03
Conditions
ventilator-associated pneumonia (VAP)ventilator-associated condition (VAC)Maxillofacial DisordersHealthcare-associated infection (HAI)sepsis
Beyond the preview
Go deeper on PACTR202601665742072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601665742072.